Sanuwave Health, INC 10-Q quarterly reports

SANUWAVE Health reports a 3% revenue increase to $9.6 million and a reduced net loss of $1.4 million for the first quarter of 2026, driven by higher disposable sales and a favorable year-over-year comparison.

SANUWAVE Health, Inc. reported a significant increase in revenue and net income for the third quarter and nine months ended September 30, 2025, driven by UltraMIST sales and a strategic debt refinancing.

SANUWAVE Health, Inc. reported significant revenue growth and improved gross margins for Q2 2025, but faces substantial doubt about its ability to continue as a going concern due to maturing debt and ongoing internal control weaknesses.

SANUWAVE Health, Inc. reports a significant 61% increase in revenue for the first quarter of 2025, driven by growth in UltraMIST disposables and systems, and announces its listing on The Nasdaq Global Market.

SANUWAVE Health experienced a significant 89% increase in revenue for the third quarter of 2024 compared to the same period last year, while still navigating financial difficulties.

SANUWAVE Health, Inc. saw a 53% increase in revenue and achieved net income for the second quarter of 2024, driven by strong sales of its UltraMIST system.

SANUWAVE Health saw a 53% increase in revenue in the first quarter of 2024 compared to the same period last year, while also progressing with its merger plans with SEP Acquisition Corp.